SEATTLE--(BUSINESS WIRE)--Jan. 6, 2006--VLST Corporation, a Seattle-based biotechnology company focused on the streamlined development of therapeutics for autoimmune and inflammatory disorders, and Accelerator Corporation, an investment vehicle supporting the formation and development of next-generation biotechnology companies, today announced the appointment of Martin A. Simonetti as president and chief executive officer of VLST. In addition, Steven Gillis, Ph.D., will join as executive chairman of VLST's Board of Directors.
